Partners

ImmunoNanoMed partners with leading experts to drive innovation in delivery methods for influenza particle-based vaccines, while supporting scale-up and commercialization efforts.

Zeteo Biomedical

Zeteo Biomedical provide “patient-centric” delivery device technology for pharma, biotech and personal care product companies utilizing novel patented packaging and device technology platforms and technical services to configure drug/device combination products for ophthalmic, nasal (systemic), nose to brain, sublingual, buccal, otic and animal care applications. 

Nanovaccine Institute

The Nanovaccine Institute is a transdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. The institute is developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and animal health.